Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration"

被引：2
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med Cluj Napoca, Dept Ophthalmol, Cluj Napoca 400014, Romania
来源：
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 2020年 / 13卷 / 02期
关键词：
POLYPOIDAL CHOROIDAL VASCULOPATHY; CLASSIFICATION;
D O I：
10.18240/ijo.2020.02.24
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [31] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [32] Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration
    Micieli, J. A.
    Wong, T.
    Lam, W. -C.
    Brent, M. H.
    Devenyi, R. G.
    Hudson, C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [33] Intravitreal Bevacizumab Injection in Patients With Neovascular Age-Related Macular Degeneration and Low Visual Acuity
    El Matri, L.
    Bouraoui, R.
    Landolsi, H.
    Kort, F.
    Chebil, A.
    Limaiem, R.
    Mghaieth, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [34] Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration
    Levy J.
    Shneck M.
    Rosen S.
    Klemperer I.
    Rand D.
    Weinstein O.
    Pitchkhadze A.
    Belfair N.
    Lifshitz T.
    International Ophthalmology, 2009, 29 (5) : 349 - 357
  • [35] Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration
    Emerson, M. Vaughn
    Lauer, Andreas K.
    Flaxel, Christina J.
    Wilson, David J.
    Francis, Peter J.
    Stout, J. Timothy
    Emerson, Geoffrey G.
    Schlesinger, Thomas K.
    Nolte, Susan K.
    Klein, Michael L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 439 - 444
  • [36] Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
    Chew, Emily Y.
    LANCET, 2024, 403 (10432): : 1110 - 1111
  • [37] Systemic and intravitreal Bevacizumab (Avastin®) in neovascular age-related macular degeneration
    Michels, S.
    Prager, F.
    Geitzenauer, W.
    Lackner, B.
    Sacu, S.
    Weigert, G.
    Kriechbaum, K.
    Polak, K.
    Georgopoulos, M.
    Schmidt-Erfurth, U.
    SPEKTRUM DER AUGENHEILKUNDE, 2007, 21 (03) : 154 - 159
  • [38] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
  • [39] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [40] Intravitreal bevacizumab (avastin) in treatment of neovascular age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    Dekaris, Iva
    Saric, Borna
    Gavric, Morena
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 77 - 81
12345